Biochemical and proteomic characterization of alkaptonuric chondrocytes

Journal of Cellular Physiology

Volumn 227, Issue 9, 2012, Pages 3333-3343

  Braconi, Daniela ^a   Bernardini, Giulia ^a   Bianchini, Claretta ^a   Laschi, Marcella ^a   Millucci, Lia ^a   Amato, Loredana ^a   Tinti, Laura ^a   Serchi, Tommaso ^a   Chellini, Federico ^b   Spreafico, Adriano ^a   Santucci, Annalisa ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ALKAPTONURIA; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL ISOLATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEOMICS; TRANSMISSION ELECTRON MICROSCOPY;

AGED; ALKAPTONURIA; APOPTOSIS; CARTILAGE; CELL PROLIFERATION; CHONDROCYTES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NITRIC OXIDE; OCHRONOSIS; OXIDATION-REDUCTION; PIGMENTATION; PROTEOME;

EID: 84862062636     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24033     Document Type: Article

References (57)

1. Aigner T, Kim HA. 2002. Apoptosis and cellular vitality: Issues in osteoarthritic cartilage degeneration. Arthritis Rheum 46: 1986-1996.
2. Aizawa T, Kon T, Einhorn TA, Gerstenfeld LC. 2001. Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 19: 785-796.
3. Angeles AP, Badger R, Gruber HE, Seegmiller JE. 1989. Chondrocyte growth inhibition induced by homogentisic acid and its partial prevention with ascorbic acid. J Rheumatol 16: 512-517.
4. Blanco Garcia FJ. 1999. Catabolic events in osteoarthritic cartilage. Osteoarthritis Cartilage 7: 308-309.
5. Braconi D, Laschi M, Amato L, Bernardini G, Millucci L, Marcolongo R, Cavallo G, Spreafico A, Santucci A. 2010a. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) 49: 1975-1983.
6. Braconi D, Laschi M, Taylor AM, Bernardini G, Spreafico A, Tinti L, Gallagher JA, Santucci A. 2010b. Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem 111: 922-932.
7. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
8. Capin-Gutierrez N, Talamas-Rohana P, Gonzalez-Robles A, Lavalle-Montalvo C, Kouri JB. 2004. Cytoskeleton disruption in chondrocytes from a rat osteoarthrosic (OA)-induced model: Its potential role in OA pathogenesis. Histol Histopathol 19: 1125-1132.
9. Cillero-Pastor B, Ruiz-Romero C, Carames B, Lopez-Armada MJ, Blanco FJ. 2010. Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum 62: 802-814.
10. De Ceuninck F, Marcheteau E, Berger S, Caliez A, Dumont V, Raes M, Anract P, Leclerc G, Boutin JA, Ferry G. 2005. Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome. J Biomol Tech 16: 256-265.
11. Facchini A, Borzi RM, Marcu KB, Stefanelli C, Olivotto E, Goldring MB, Facchini A, Flamigni F. 2005. Polyamine depletion inhibits NF-kappaB binding to DNA and interleukin-8 production in human chondrocytes stimulated by tumor necrosis factor-alpha. J Cell Physiol 204: 956-963.
12. Fernandes JC, Martel-Pelletier J, Pelletier JP. 2002. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237-246.
13. Fernandez-Canon JM, Granadino B, Beltran-Valero deBernabe, Renedo D, Fernandez-Ruiz M, Penalva E, Rodriguez MA, de Cordoba S. 1996. The molecular basis of alkaptonuria. Nat Genet 14: 19-24.
14. Fioravanti A, Nerucci F, Annefeld M, Collodel G, Marcolongo R. 2003. Morphological and cytoskeletal aspects of cultivated normal and osteoarthritic human articular chondrocytes after cyclical pressure: A pilot study. Clin Exp Rheumatol 21: 739-746.
15. Fischer BA, Mundle S, Cole AA. 2000. Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50: 236-242.
16. Flannery CR, Little CB, Hughes CE, Curtis CL, Caterson B, Jones SA. 2000. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biol 19: 549-553.
17. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM. 2007. High abundance synovial fluid proteome: Distinct profiles in health and osteoarthritis. Arthritis Res Ther 9: R36.
18. Grimmer C, Balbus N, Lang U, Aigner T, Cramer T, Muller L, Swoboda B, Pfander D. 2006. Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: Possible influence of low oxygen levels. Am J Pathol 169: 491-502.
19. Helliwell TR, Gallagher JA, Ranganath L. 2008. Alkaptonuria-A review of surgical and autopsy pathology. Histopathology 53: 503-512.
20. Henrotin Y, Kurz B, Aigner T. 2005. Oxygen and reactive oxygen species in cartilage degradation: Friends or foes? Osteoarthritis Cartilage 13: 643-654.
21. Holloway I, Kayser M, Lee DA, Bader DL, Bentley G, Knight MM. 2004. Increased presence of cells with multiple elongated processes in osteoarthritic femoral head cartilage. Osteoarthritis Cartilage 12: 17-24.
22. Honorati MC, Bovara M, Cattini L, Piacentini A, Facchini A. 2002. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 10: 799-807.
23. Iliopoulos D, Gkretsi V, Tsezou A. 2010. Proteomics of osteoarthritic chondrocytes and cartilage. Expert Rev Proteomics 7: 749-760.
24. Isomaki P, Punnonen J. 1997. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 29: 499-507.
25. Jorgensen C, Apparailly F, Couret I, Canovas F, Jacquet C, Sany J. 1998. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 93: 518-523.
26. Juang YM, Lee CY, Hsu WY, Lin CT, Lai CC, Tsai FJ. 2010. Proteomic analysis of chondrocytes exposed to pressure. Biomed Chromatogr 24: 1273-1282.
27. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179: 1517-1527.
28. Kim HA, Blanco FJ. 2007. Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets 8: 333-345.
29. Kirkpatrick CJ, Mohr W, Mutschler W. 1984. Experimental studies on the pathogenesis of ochronotic arthropathy. The effects of homogentisic acid on adult and fetal articular chondrocyte morphology, proliferative capacity and synthesis of proteoglycans in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol 47: 347-360.
30. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. 2005. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52: 128-135.
31. Kokebie R, Aggarwal R, Lidder S, Hakimiyan AA, Rueger DC, Block JA, Chubinskaya S. 2011. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther 13: R50.
32. Kutty MK, Iqbal QM, Teh EC. 1973. Ochronotic arthropathy. A comparative study of light microscopic and ultrastructural features. Arch Pathol 96: 100-103.
33. La Du BN, Jr. 1991. Alcaptonuria and ochronotic arthritis. Mol Biol Med 8: 31-38.
34. La Du BN, Zannoni VG, Laster L, Seegmiller JE. 1958. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230: 251-260.
35. Lechman ER, Jaffurs D, Ghivizzani SC, Gambotto A, Kovesdi I, Mi Z, Evans CH, Robbins PD. 1999. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 163: 2202-2208.
36. Li H, Yang HS, Wu TJ, Zhang XY, Jiang WH, Ma QL, Chen YX, Xu Y, Li S, Hua ZC. 2010. Proteomic analysis of early-response to mechanical stress in neonatal rat mandibular condylar chondrocytes. J Cell Physiol 223: 610-622.
37. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, Geng Y. 1995. Cytokine regulation of chondrocyte functions. J Rheumatol SUPPL 43: 104-108.
38. Mathy-Hartert M, Hogge L, Sanchez C, Deby-Dupont G, Crielaard JM, Henrotin Y. 2008. Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: A possible explanation for oxidative stress generation. Osteoarthritis Cartilage 16: 756-763.
39. Moo V, Sieper J, Herzog V, Muller BM. 2001. Regulation of expression of cytokines and growth factors in osteoarthritic cartilage explants. Clin Rheumatol 20: 353-358.
40. Muller RD, John T, Kohl B, Oberholzer A, Gust T, Hostmann A, Hellmuth M, Laface D, Hutchins B, Laube G, Veh RW, Tschoeke SK, Ertel W, Schulze-Tanzil G. 2008. IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro. Cytokine 44: 377-385.
41. O'Brien WM, La Du BN, Bunim JJ. 1963. Biochemical, pathologic and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy: Review of world literature (1584-1962). Am J Med 34: 813-838.
42. Pelletier JP, Martel-Pelletier J, Abramson SB. 2001. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 44: 1237-1247.
43. Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL, Anderson PD, Huizing M, Anikster Y, Gerber LH, Gahl WA. 2002. Natural history of alkaptonuria. N Engl J Med 347: 2111-2121.
44. Rediske JJ, Koehne CF, Zhang B, Lotz M. 1994. The inducible production of nitric oxide by articular cell types. Osteoarthritis Cartilage 2: 199-206.
45. Reinheckel T, Korn S, Mohring S, Augustin W, Halangk W, Schild L. 2000. Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/reoxygenation in isolated rat liver mitochondria. Arch Biochem Biophys 376: 59-65.
46. Ruiz-Romero C, Carreira V, Rego I, Remeseiro S, Lopez-Armada MJ, Blanco FJ. 2008. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 8: 495-507.
47. Selvi E, Manganelli S, Mannoni A, Benucci M, Minacci C, Marcolongo R. 2000. Chronic ochronotic arthritis: Clinical, arthroscopic, and pathologic findings. J Rheumatol 27: 2272-2274.
48. Spreafico A, Frediani B, Capperucci C, Chellini F, Paffetti A, D'Ambrosio C, Bernardini G, Mini R, Collodel G, Scaloni A, Marcolongo R, Santucci A. 2006. A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 6: 3520-3532.
49. Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, Serchi T, Collodel G, Paffetti A, Fossombroni V, Galeazzi M, Marcolongo R, Santucci A. 2009. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108: 1153-1165.
50. Switzer RC, III, Merril CR, Shifrin S. 1979. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 98: 231-237.
51. Theos AC, Tenza D, Martina JA, Hurbain I, Peden AA, Sviderskaya EV, Stewart A, Robinson MS, Bennett DC, Cutler DF, Bonifacino JS, Marks MS, Raposo G. 2005. Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes. Mol Biol Cell 16: 5356-5372.
52. Tinti L, Spreafico A, Braconi D, Millucci L, Bernardini G, Chellini F, Cavallo G, Selvi E, Galeazzi M, Marcolongo R, Gallagher JA, Santucci A. 2010. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 225: 84-91.
53. Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A. 2011a. A novel ex vivo organotypic culture model of alkaptonuria-ochronosis. Clin Exp Rheumatol 29: 693-696.
54. Tinti L, Taylor AM, Santucci A, Wlodarski B, Wilson PJ, Jarvis JC, Fraser WD, Davidson JS, Ranganath LR, Gallagher JA. 2011b. Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology 50: 271-277.
55. Umlauf D, Frank S, Pap T, Bertrand J. 2010. Cartilage biology, pathology, and repair. Cell Mol Life Sci 67: 4197-4211.
56. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, Muller PE, Evans CH, Porter RM. 2009. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 60: 801-812.
57. Zannoni VG, Malwista SE, La Du BN. 1962. Studies on ochronosis II. Studies on benzoquinoneacetic acid, a probable intermediate in the connective tissue pigmentation in alkaptonuria. Arthritis Rheum 5: 547-556.